MX2007013683A - Tetrahidropirimidinas antitumorales. - Google Patents

Tetrahidropirimidinas antitumorales.

Info

Publication number
MX2007013683A
MX2007013683A MX2007013683A MX2007013683A MX2007013683A MX 2007013683 A MX2007013683 A MX 2007013683A MX 2007013683 A MX2007013683 A MX 2007013683A MX 2007013683 A MX2007013683 A MX 2007013683A MX 2007013683 A MX2007013683 A MX 2007013683A
Authority
MX
Mexico
Prior art keywords
substituted
unsubstituted
alkyl
optionally substituted
group
Prior art date
Application number
MX2007013683A
Other languages
English (en)
Spanish (es)
Inventor
Jose Fernando Reyes Benitez
Maria Del Carmen Cuevas Marchante
David Montalvo Lobo
Ma Jesus Martin Lopez
Maria Cristina Mateo Urbano
Andres Francesch Solloso
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of MX2007013683A publication Critical patent/MX2007013683A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2007013683A 2005-05-03 2006-05-03 Tetrahidropirimidinas antitumorales. MX2007013683A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05076037 2005-05-03
PCT/EP2006/004117 WO2006117197A1 (en) 2005-05-03 2006-05-03 Antitumoral tetrahydro-pyrimidines

Publications (1)

Publication Number Publication Date
MX2007013683A true MX2007013683A (es) 2007-12-03

Family

ID=36649783

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007013683A MX2007013683A (es) 2005-05-03 2006-05-03 Tetrahidropirimidinas antitumorales.

Country Status (13)

Country Link
US (1) US20100216817A1 (enExample)
EP (1) EP1879870A1 (enExample)
JP (1) JP2008540362A (enExample)
KR (1) KR20080007640A (enExample)
CN (1) CN101171236A (enExample)
AU (1) AU2006243407A1 (enExample)
CA (1) CA2605784A1 (enExample)
EA (1) EA013160B1 (enExample)
IL (1) IL186781A0 (enExample)
MX (1) MX2007013683A (enExample)
NO (1) NO20076162L (enExample)
NZ (1) NZ563054A (enExample)
WO (1) WO2006117197A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210868A (zh) * 2011-04-29 2011-10-12 济南环肽医药科技有限公司 四氢嘧啶及其衍生物在制备口服吸收促进剂中的应用
LT3615544T (lt) 2017-04-27 2023-05-10 Pharma Mar S.A. Priešnavikiniai junginiai
CN108120792B (zh) * 2017-12-14 2020-03-24 青海出入境检验检疫局检验检疫综合技术中心 一种四氢嘧啶的高效液相检测及含量测定方法
CN110156697B (zh) * 2019-05-30 2022-05-06 常州沃腾化工科技有限公司 一种1,2-二甲基-1,4,5,6-四氢嘧啶的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2743255A (en) * 1952-12-19 1956-04-24 Petrolite Corp Amine-modified thermoplastic phenolaldehyde resins and method of making same
US4292429A (en) * 1978-03-08 1981-09-29 Ciba-Geigy Corporation Imidazole urea and amido compounds

Also Published As

Publication number Publication date
JP2008540362A (ja) 2008-11-20
KR20080007640A (ko) 2008-01-22
EA013160B1 (ru) 2010-02-26
NZ563054A (en) 2010-09-30
EP1879870A1 (en) 2008-01-23
CN101171236A (zh) 2008-04-30
NO20076162L (no) 2007-11-29
AU2006243407A1 (en) 2006-11-09
CA2605784A1 (en) 2006-11-09
US20100216817A1 (en) 2010-08-26
IL186781A0 (en) 2008-02-09
WO2006117197A1 (en) 2006-11-09
EA200702397A1 (ru) 2008-02-28

Similar Documents

Publication Publication Date Title
TWI791511B (zh) 細胞凋亡誘導劑
US6180636B1 (en) Substituted pyrrolopyrimidines and processes for their preparation
US20220227738A1 (en) Kras g12c inhibitors and uses thereof
WO2022115439A1 (en) Kras g12c inhibitors and uses thereof
SI9620103A (sl) Pirolopirimidini in postopki za njihovo pripravo
WO2003055890A1 (en) Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
US20110178170A1 (en) Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
Mathew et al. Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors
RU2129546C1 (ru) 6,9-бис(аминозамещенные)-бензо(g)изохинолин-5,10-дионы, способ их получения, фармацевтическая композиция на их основе и способ ингибирования опухолей у млекопитающих
US7507739B2 (en) 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents
JP5558470B2 (ja) エピポドフィロトキシンの新規な（ポリ）アミノアルキルアミノアルキルアミド、アルキル−尿素またはアルキル−スルホンアミド誘導体、それらの製造方法、および治療における抗癌剤としてのそれらの応用
US20040132786A1 (en) Differential tumor cytotoxicity compounds and compositions
AU759618B2 (en) Tan-1057 derivatives
WO2006117197A1 (en) Antitumoral tetrahydro-pyrimidines
US7915266B2 (en) 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents
CA2076431A1 (en) Condensed pyrimidine derivative
JP3425676B2 (ja) 縮合ピリミジン誘導体、その製造法および用途
US20030181722A1 (en) LK6-A derivatives
EP1910326A1 (en) Antitumoral compounds
US5019577A (en) Novel compounds and use
WO2007010307A1 (en) Antineoplastic compounds
ES2288795A1 (es) Compuestos antitumorales.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal